» Articles » PMID: 19213697

One-step, Multiplex, Real-time PCR Assay with Molecular Beacon Probes for Simultaneous Detection, Differentiation, and Quantification of Human T-cell Leukemia Virus Types 1, 2, and 3

Overview
Specialty Microbiology
Date 2009 Feb 14
PMID 19213697
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A single-tube, multiplex, real-time PCR assay with molecular beacons was established in which various probes were used for the simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3 (HTLV-1, HTLV-2, and HTLV-3, respectively) and of simian T-cell leukemia virus types 1 and 3 (STLV-1 and STLV-3, respectively). The quantitative amplification of the standards with MT4 (HTLV-1) and C19 (HTLV-2) cell lines and a molecular clone of HTLV-3 was linear, with the simplex and multiplex methods having similar efficiencies. A maximum difference of 0.9 (mean, 0.4; range, 0.0 to 0.9) was found between threshold cycle values in single and multiplex reactions. The efficiency with each probe in the multiplex reaction was close to 100%, indicating strong linear amplification. The albumin gene was used to standardize the copy number. Comparable results for the detection and quantification of HTLV-1 were obtained with our new methods and with other real-time PCR methods described previously. With our new multiplex assay, however, we were able to detect and quantify HTLV-2 and -3 and STLV-1 and -3 in clinical specimens, with an excellent dynamic range of 10(6) to 10(0) copies per assay, which the other assays could not do. Thus, it will be possible to determine a wide range of HTLV types in both standard and clinical samples, with a detection of 1 to 10 HTLV copies in samples containing at least 100 cells. Furthermore, our system can provide evidence for multiple infections with the three HTLV types, with separate proviral load results. Our new method also could be used for epidemiological studies in Africa and in countries where HTLVs and STLVs are endemic.

Citing Articles

Human T-Cell Leukemia Virus Type 1-Related Diseases May Constitute a Threat to the Elimination of Human Immunodeficiency Virus, by 2030, in Gabon, Central Africa.

Oloumbou E, Engone-Ondo J, Mamimandjiami Idam I, Moussavou-Boudzanga P, Mfouo-Tynga I, Mouinga-Ondeme A Viruses. 2022; 14(12).

PMID: 36560812 PMC: 9785256. DOI: 10.3390/v14122808.


Rapid and Sensitive Qualitative Duoplex Real-Time PCR Method for Discriminatory and Confirmatory Diagnosis of HTLV-1 and HTLV-2 Infections: Brazilian Multicentric Study.

Rocha-Junior M, Rodrigues E, Slavov S, Assone T, Pedreschi M, de La Roque D Front Med (Lausanne). 2022; 9:881630.

PMID: 35755037 PMC: 9218175. DOI: 10.3389/fmed.2022.881630.


Development and Validation of Multiplex Quantitative Real-Time PCR Assays for Simultaneous Detection and Differentiation of HTLV-1 and HTLV-2, Using Different PCR Platforms and Reagent Brands.

Goncalves M, Fukasawa L, Campos K, Takenori Higa F, Caterino-de-Araujo A Front Microbiol. 2022; 13:831594.

PMID: 35369428 PMC: 8965094. DOI: 10.3389/fmicb.2022.831594.


Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.

Caron M, Besson G, Padilla C, Makuwa M, Nkoghe D, Leroy E PLoS Negl Trop Dis. 2018; 12(10):e0006833.

PMID: 30359373 PMC: 6201875. DOI: 10.1371/journal.pntd.0006833.


Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire.

Switzer W, Tang S, Zheng H, Shankar A, Sprinkle P, Sullivan V PLoS One. 2016; 11(6):e0157709.

PMID: 27310836 PMC: 4911074. DOI: 10.1371/journal.pone.0157709.


References
1.
Bonnet G, Tyagi S, Libchaber A, Kramer F . Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci U S A. 1999; 96(11):6171-6. PMC: 26854. DOI: 10.1073/pnas.96.11.6171. View

2.
Lacoste V, Judde J, Bestett G, Cadranel J, Antoine M, Valensi F . Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses. Leuk Lymphoma. 2000; 38(3-4):401-9. DOI: 10.3109/10428190009087032. View

3.
Gallo D, Penning L, Hanson C . Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method. J Clin Microbiol. 1991; 29(10):2345-7. PMC: 270328. DOI: 10.1128/jcm.29.10.2345-2347.1991. View

4.
Tse C, Capeau J . [Real time PCR methodology for quantification of nucleic acids]. Ann Biol Clin (Paris). 2003; 61(3):279-93. View

5.
Mortreux F, Kazanji M, Gabet A, de Thoisy B, Wattel E . Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus). J Virol. 2001; 75(2):1083-9. PMC: 114008. DOI: 10.1128/JVI.75.2.1083-1089.2001. View